Windtree Therapeutics Stock (NASDAQ: WINT)

Windtree Therapeutics (NASDAQ:WINT) Stock, Quote.Headers.trade-ideas

Windtree Therapeutics

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AGFY

EFSH

GLMD

HCTI

IOBT

ISPC

LUNR

MKDW

NEGG

OMEX

PRTG

SMSI

TNON

VEEA

VVPR

WATT

WBUY

WINT

XXII

Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket

pharmaceutical ARDX Ardelyx

Windtree Therapeutics shares are trading higher Wednesday after the company completed enrollment of its SEISMiC Extension Phase 2b study of istaroxime.

What&#39;s Going On With Windtree Therapeutics Stock Wednesday?

Intraday Update

AAOI

AGMH

AIXI

AMAT

APDN

ASST

ATPC

AUUD

AVTX

BNRG

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNFR

FEDU

GERN

INTC

KROS

LITB

MNOV

MRVL

MSGM

NVAX

NVCR

NVMI

PCVX

PSNY

QNTM

RXRX

SGRP

SHLS

SIFY

SLXN

STRL

TCBP

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics Inc

Windtree Therapeutics Inc arrants (25/03/2026)

WINTO GROUP HLDGS LTD by WINTO GROUP HLDGS LTD.

Wintrust Financial Corporation - Common Stock

Wintrust Financial Corp

Wintrust Financial Corporation - Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D

Wintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E

JP Morgan analyst Matthew Boss downgrades Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) from Neutral to Underweight and raises the price target from $89 to $95.

Downgrades

Price Target

Analyst Ratings

FIVE

JP Morgan Downgrades Five Below to Underweight, Raises Price Target to $95

INAQ's Special Meeting of Stockholders to Approve the Business Combination Scheduled to be Held on October 14, 2024
CORNELIUS, N.C. and NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Corp. ("Alpha Modus"), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp. ("Insight") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAQ#NASDAQ">INAQ</a>), a publicly traded special purpose acquisition company, announced today that the U.S. Securities and Exchange Commission ("SEC") has declared effective the registration statement on Form S-4 (as amended, the "Registration Statement") filed with the SEC related to the previously announced business combination (the "Business Combination"). Insight has also filed with the SEC the definitive proxy statement for its special meeting of stockholders (the "Special Meeting"), to, among other things, approve the Business Combination. &nbsp;
Upon closing of the Business Combination, which is subject to stockholder approval, the combined company will operate as "Alpha Modus Holdings, Inc." and its common stock and warrants are expected to commence trading on the Nasdaq Global Market ("Nasdaq") under the tickers "AMOD" and "AMODW", respectively, shortly thereafter.
For additional details regarding the Business Combination, please see the sources described below under, "Important Information About the Proposed Business Combination and Where to Find It".

INAQ

Alpha Modus And Insight Acquisition Corp. Announce Effectiveness Of Form S-4 Registration Statement For Proposed Business Combination,  Expects To Commence Trading On The Nasdaq Global Market Under The Tickers "AMOD"

Leerink Partners analyst Mani Foroohar reiterates 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Outperform and lowers the price target from $40 to $36.

Reiteration

FDMT

Leerink Partners Reiterates Outperform on 4D Molecular Therapeutics, Lowers Price Target to $36

RBC Capital analyst Luca Issi reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Outperform and maintains $300 price target.

ALNY

RBC Capital Reiterates Outperform on Alnylam Pharmaceuticals, Maintains $300 Price Target

(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize&nbsp;Cube's&nbsp;AI-driven, multi-omic&nbsp;platform for&nbsp;early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutions.

Biotech

General

RENB

PersonalAIze And RenovaroCube Announce A Strategic Partnership To Develop, Validate, And Commercialize Cube's AI-Driven Platform For Early Detection Of Cancer And Other Diseases

TNDM

Tandem's t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin In The European Union

Jewett-Cameron Trading Company Ltd. ("Jewett-Cameron") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCTCF#NASDAQ">JCTCF</a>), a company committed to innovative products that enrich outdoor spaces, today announced it has retained one of the industry's leading investor relations firms, Lytham Partners, LLC, to lead a strategic investor relations and shareholder communication program. &nbsp;
For more than 20 years, Lytham Partners has cultivated a highly diverse network of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform enabling far-reaching exposure to investors in a consistent and in-depth format including the Lytham Partners Investor Conference Series. This platform includes a communications and positioning approach that is achieved through various means, including via press releases, conference calls, investor presentations, profiles, corporate access, and websites.

JCTCF

Jewett-Cameron Announces It Has Retained An Investor Relations Firms, Lytham Partners, LLC, To Lead A Strategic Investor Relations And Shareholder Communication Program

RealVision&#8217;s chief crypto analyst Jamie Coutts shared his insights on the current crypto market downturn, hinting at a potential bullish shift based <a href="https://www.benzinga.com/money/what-you-need-to-know-about-technical-analysis">on technical indicators</a>.
What Happened: In a detailed <a href="https://x.com/Jamie1Coutts/status/1836192082127655274">thread</a> of X, Coutts highlighted a 55% pullback of the top 200 cryptocurrencies equally weighed over the past six months. 
He noted that despite the downtrend, the risk/reward ratio is favorable for adding to select assets at these levels. Coutts also pointed out a sharp move higher on the altseason indicator, suggesting a potential end to the bearish thrust.
He further explained that a return to a bullish regime could be indicated when more than 45% of assets trade above their 200-day moving average. Currently, only 11% of assets are above this mark.
Coutts believes that traders will need the price to break out of downtrends, but for allocators, current price levels are desirable to add as the risk/reward is favorable.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40926060/bitcoin-is-in-for-a-massive-bull-run-if-this-2020-pattern-repeats-analyst-says">Bitcoin Is In For A &#8216;Massive Bull Run&#8217; If This 2020 Pattern Repeats, Analyst Says</a>
Why It Matters: Coutts' analysis contrasts the last months of persistent sideways trading. The analyst sees early signs of a potential reversal, similar to that in Q3 2023.
He also emphasized the role of liquidity in driving the market, stating that it has now turned decisively bullish and is <a href="https://x.com/Jamie1Coutts/status/1824053788027851175">likely</a> to push Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) higher. 
Despite the price decline over the past six months, key crypto ecosystem fundamental metrics have performed well, with addresses up by 73% and rising transactions.
While acknowledging the current bearish price action, Coutts suggested that the final throes of the big flush of the past months could make Q4 critical for 12-month forward returns for allocators.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40919168/ethereum-co-founder-says-donald-trump-is-certainly-the-favorite-over-kamala-harris-for-cry">Ethereum Co-Founder Says Donald Trump Is &#8216;Certainly The Favorite&#8217; Over Kamala Harris For Crypto</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Raoul Pal's Chief Crypto Analyst Says The Bull Market Is Back When This Indicator Hits 45% (It's Now At 11%)

Iconic Golf Simulator Company Awards Local Entrepreneurs&nbsp;Opportunity to Develop 80 New Centers
CHICAGO, Sept. 19, 2024 /PRNewswire/ -- TruGolf Links Franchising, LLC ("TruGolf"), owned by TruGolf Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUG#NASDAQ">TRUG</a>), a leading provider of golf simulator software and hardware, announced today the signing of its second regional development deal. Led by experienced entrepreneurs Bob Early and Ron&nbsp;Rzansa, the deal spans the surrounding Chicago suburbs and into the northwest region of Indiana. The agreement includes the rights to open 80 locations, either owned or franchised, with plans to hit the markets aggressively and create close ties within local communities across the region.

TRUG

TruGolf Links Announces The Signing Of Its Second Regional Development Deal, Includes The Rights To Open 80 Locations, Either Owned Or Franchised, With Plans To Hit The Markets Aggressively And Create Close Ties Within Local Communities Across The Region

Leerink Partners analyst Joseph Schwartz maintains Applied Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) with a Outperform and raises the price target from $11 to $14.

APLT

Leerink Partners Maintains Outperform on Applied Therapeutics, Raises Price Target to $14

Jefferies analyst Julien Dumoulin-Smith initiates coverage on NextEra Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) with a Buy rating and announces Price Target of $28.

Initiation

Jefferies Initiates Coverage On NextEra Energy Partners with Buy Rating, Announces Price Target of $28

WIIM

PLUG

Plug Power shares are trading higher after the company launched an equipment lease financing platform.

In the preceding three months, 5 analysts have released ratings for Regal Rexnord (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRX#NYSE">RRX</a>), presenting a wide array of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $195.6, a high estimate of $213.00, and a low estimate of $180.00. This current average has increased by 0.31% from the previous average price target of $195.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726750871_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of Regal Rexnord by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$195.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$213.00</td>
<td>$208.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$180.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Jeffrey Hammond</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$210.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Regal Rexnord. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Regal Rexnord compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Regal Rexnord's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Regal Rexnord's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/RRX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Regal Rexnord analyst ratings.</a>
<h2>Delving into Regal Rexnord's Background</h2>
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors and electronic controls, air moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
<h3>Understanding the Numbers: Regal Rexnord's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Negative Revenue Trend: Examining Regal Rexnord's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -12.5% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Regal Rexnord's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.04% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.99%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Regal Rexnord's ROA stands out, surpassing industry averages. With an impressive ROA of 0.42%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Regal Rexnord's debt-to-equity ratio surpasses industry norms, standing at 0.93. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 5 Analyst Recommendations For Regal Rexnord

Analysts' ratings for Vista Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTO#NYSE">VSTO</a>) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $41.17, with a high estimate of $43.00 and a low estimate of $40.00. This current average reflects an increase of 1.91% from the previous average price target of $40.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1726750863_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Vista Outdoor. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matt Koranda</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Eric Wold</td>
<td>B. Riley Securities</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$43.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Rommel Dionisio</td>
<td>Aegis Capital</td>
<td>Announces</td>
<td>Hold</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Mark Smith</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Hold</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Matt Koranda</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Matt Koranda</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Vista Outdoor. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Vista Outdoor compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Vista Outdoor's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Vista Outdoor's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VSTO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Vista Outdoor analyst ratings.</a>
<h2>Discovering Vista Outdoor: A Closer Look</h2>
Vista Outdoor Inc designs, develops, and manufactures outdoor sports and recreation products, and is domiciled in the United States. The company operates through the following reportable segments: the Kinetic Group, Revelyst Outdoor Performance, Revelyst Adventure Sports, and Revelyst Precision Sports Technology. The majority of the company's revenue is generated from its Kinetic Group segment which consists of its ammunition brands and provides ammunition used for training, hunting, target shooting, and personal protection.
<h3>Vista Outdoor's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Negative Revenue Trend: Examining Vista Outdoor's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -7.09% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Vista Outdoor's net margin is impressive, surpassing industry averages. With a net margin of 8.87%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Vista Outdoor's ROE stands out, surpassing industry averages. With an impressive ROE of 4.94%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Vista Outdoor's ROA stands out, surpassing industry averages. With an impressive ROA of 2.4%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Vista Outdoor's debt-to-equity ratio is below the industry average. With a ratio of 0.63, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VSTO

Beyond The Numbers: 6 Analysts Discuss Vista Outdoor Stock

On CNBC's <a href="https://www.cnbc.com/video/2024/09/18/final-trades-energy-transfer-trade-desk-alphabet-and-general-motors.html">&#8220;Halftime Report Final Trades,&#8221;</a> Jim Lebenthal said General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) benefits from rate cuts.
General Motors, last week, agreed to explore collaboration with Hyundai Motor and expand its partnership with EVgo by installing 400 fast-charging stalls at key locations in major U.S. metropolitan areas. Additionally, the company is reportedly in talks to buy Chinese batteries made in the U.S. through its <a href="https://www.benzinga.com/markets/penny-stocks/24/09/40905775/gm-and-hyundai-join-forces-to-boost-competitiveness-and-improve-efficiency">partnership with Japan's TDK</a>.
Bryn Talkington of Requisite Capital Management named Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>), an energy play, which is up 16% year-to-date. The company also has a dividend<a href="https://www.benzinga.com/quote/ET/analyst-ratings"> yield of 8%, she added</a>.
On Wednesday, UBS analyst Shneur Gershuni maintained Energy Transfer with a Buy rating and raised the price target from $22 to $23.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Joseph M. Terranova of Virtus Investment Partners said The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>), is pushing back to its Nov. 2021 all-time high level.
On Sept. 13, Wedbush analyst Scott Devitt maintained Trade Desk with an Outperform rating and raised the price target from $110 to $115.
Stephen Weiss of Short Hills Capital Partners said Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) is still undervalued.
Alphabet Google won its appeal against the European Commission&#8217;s €1.49 billion ($1.66 billion) antitrust fine for anticompetitive practices involving its online search advertising business. Luxembourg-based General Court delivered a reprieve to Google, nullifying the line about the $1.66 billion penalty in the European Commission&#8217;s five-year-old <a href="https://www.benzinga.com/24/09/40915828/google-wins-1-7b-eu-antitrust-fine-appeal-over-5-year-old-online-search-advertising-case">order against the search giant, reported Reuters.</a>
Price Action:
<ul>
<li>Energy Transfer gained 0.6% to close at $16.11 during Wednesday's session.</li>
<li>Trade Desk shares gained 2.1% to settle at $108.02 on Wednesday.</li>
<li>Alphabet shares gained 0.3% to close at $160.81 during Wednesday's session.</li>
<li>General Motors shares gained 2.4% to settle at $48.66 on Wednesday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40927530/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>
Image: Shutterstock

Long Ideas

Media

GOOG

GOOGL

General Motors, Alphabet, Trade Desk And An Energy Stock On CNBC's 'Final Trades'

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Kodiak Gas Services and provided 12-month price targets. The average target is $33.0, accompanied by a high estimate of $35.00 and a low estimate of $29.00. This current average reflects an increase of 6.45% from the previous average price target of $31.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726750827_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of Kodiak Gas Services by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sebastian Erskine</td>
<td>Redburn Atlantic</td>
<td>Announces</td>
<td>Buy</td>
<td>$35.00</td>
<td>-</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$31.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Selman Akyol</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kodiak Gas Services. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kodiak Gas Services compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Kodiak Gas Services's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Kodiak Gas Services's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/KGS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kodiak Gas Services analyst ratings.</a>
<h2>Delving into Kodiak Gas Services's Background</h2>
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Compression Operations and Other Services. Compression Operations consist of operating company-owned and customer-owned compression infrastructure for customers, pursuant to fixed-revenue contracts to enable the production, gathering and transportation of natural gas and oil. Other Services consist of a full range of contract services to support the needs of customers, including station construction, maintenance and overhaul and other ancillary time and material-based offerings.
<h3>Kodiak Gas Services's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Kodiak Gas Services displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 52.31%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 2.17%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.55%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Kodiak Gas Services's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.17%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.95, Kodiak Gas Services faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 5 Analyst Recommendations For Kodiak Gas Services

Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $14.89, along with a high estimate of $22.00 and a low estimate of $9.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.31%. 
<img src="https://www.benzinga.com/files/images/story/2024/1726750819_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Coursera among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nafeesa Gupta</td>
<td>B of A Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$11.00</td>
<td>-</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Jeffrey Silber</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$11.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Eric Sheridan</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$9.00</td>
<td>$10.50</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$15.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Jason Celino</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$12.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Coursera. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Coursera compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Coursera's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coursera's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COUR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coursera analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Coursera</h2>
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
<h3>A Deep Dive into Coursera's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Coursera's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 10.82%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Coursera's net margin excels beyond industry benchmarks, reaching -13.49%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.85%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -2.52%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Coursera's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.0.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COUR

Demystifying Coursera: Insights From 9 Analyst Reviews

Ratings for HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) were provided by 22 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for HubSpot, presenting an average target of $596.55, a high estimate of $730.00, and a low estimate of $460.00. Observing a downward trend, the current average is 9.57% lower than the prior average price target of $659.71. 
<img src="https://www.benzinga.com/files/images/story/2024/1726750809_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of HubSpot by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$730.00</td>
<td>$730.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$570.00</td>
<td>$570.00</td>
</tr>
<tr>
<td>Drew Foster</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$629.00</td>
<td>$699.00</td>
</tr>
<tr>
<td>Ryan Macwilliams</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$500.00</td>
<td>$575.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$730.00</td>
<td>$730.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$700.00</td>
<td>$700.00</td>
</tr>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Sector Weight</td>
<td>$460.00</td>
<td>-</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$580.00</td>
<td>$650.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$675.00</td>
<td>$725.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$570.00</td>
<td>$635.00</td>
</tr>
<tr>
<td>Taylor McGinnis</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$550.00</td>
<td>$580.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$625.00</td>
<td>$650.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$550.00</td>
<td>$650.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$600.00</td>
<td>$700.00</td>
</tr>
<tr>
<td>Richard Davis</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$600.00</td>
<td>$700.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$570.00</td>
<td>$570.00</td>
</tr>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$600.00</td>
<td>$700.00</td>
</tr>
<tr>
<td>Ken Wong</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$625.00</td>
<td>$725.00</td>
</tr>
<tr>
<td>Taylor McGinnis</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$580.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$460.00</td>
<td>$520.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$570.00</td>
<td>$655.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$650.00</td>
<td>$750.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to HubSpot. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of HubSpot compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of HubSpot's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of HubSpot's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HUBS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on HubSpot analyst ratings.</a>
<h2>About HubSpot</h2>
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
<h3>Financial Milestones: HubSpot's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining HubSpot's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 20.43% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: HubSpot's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -2.27%, the company may face hurdles in effective cost management.
Return on Equity (ROE): HubSpot's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.95%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): HubSpot's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.44%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.48, HubSpot adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HUBS

The Analyst Landscape: 22 Takes On HubSpot

BNZIW

Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times

Jefferies analyst Julien Dumoulin-Smith initiates coverage on NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) with a Hold rating and announces Price Target of $87.

Jefferies Initiates Coverage On NextEra Energy with Hold Rating, Announces Price Target of $87

The latest update is out from Windtree Therapeutics (WINT). Windtree Therapeutics, Inc. has entered into a Securities Purchase Agreement for a priv...

Windtree Therapeutics Raises Funds Through Strategic Securities Placement

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Windtree Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing higher on Friday after the biotechnology company provided an update on its <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">clinical trial of istaroxime</a>.



Windtree Therapeutics notes that it is expecting its Phase 2 Phase 2 SEISMiC Extension Study to complete enrollment within the company weeks. This is testing the use of istaroxime on SCAI Stage B early cardiogenic shock patients.



Windtree Therapeutics also notes that it will have topline data from this study ready be the end of the quarter. This builds on prior successful Phase 2 studies of istaroxime as the company plans for a Phase 3 clinical trial.



Additionally, Windtree Therapeutics is gearing up for a study of istaroxime to treat SCAI Stage C cardiogenic shock patients.&nbsp;These are more ill than those with SCAI Stage B early cardiogenic shock.



Windtree Therapeutics chairman and CEO Craig Fraser said the following.




&ldquo;We are pleased with our progress in clinical development because of the importance of the high unmet needs in the patient populations we are studying.&rdquo;




<h2>WINT Stock Movement on Friday</h2>



With all of this news comes heavy trading of WINT stock. That has more than 5 million of the company&rsquo;s shares changing hands. This is well above its daily average trading volume of about 50,000 shares.



WINT stock is up 116% as of Friday morning.



Investors will want to keep reading for more of the most recent stock market news today!



We have all of the hottest stock market news ready to go on Friday! That includes the biggest pre-market stock movers this morning and other recent happenings. You can catch up on all of this below!



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>



<li><a href="https://investorplace.com/2024/07/ticker-mix-up-the-container-store-tcs-stock-soars-despite-no-clear-news/">Ticker Mix-Up? The Container Store (TCS) Stock Soars Despite No Clear News.</a></li>



<li><a href="https://investorplace.com/2024/07/tsla-stock-elon-musk-says-tesla-board-will-review-xai-investment-proposal/">TSLA Stock: Elon Musk Says Tesla Board Will Review xAI Investment Proposal</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-windtree-therapeutics-wint-stock-up-116-today/">Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
BurgerFi International&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) stock is taking off on Friday after the fast-casual food company announced a settlement agreement with Lion Point Capital, LP.



This will have BurgerFi International paying $1.35 million to Lion Point Capital, LP. It will also see it issue the company 300,000 shares of Series A Preferred Stock.



This agreement will close out the current litigation between BurgerFi International and Lion Point Capital, LP. That lawsuit included allegations that BurgerFi International failed to timely register Lion Point Capital, LP&rsquo;s, violating a registration rights agreement.



David Heidecorn, chairman of the board at BurgerFi International, said the following about the settlement news.




&ldquo;We are pleased to be putting this litigation matter with Lion Point firmly behind us. Our intention is to continue to explore strategic alternatives that we believe would be in the best interests of the Company and its stakeholders, as previously disclosed.&rdquo;




<h2>BFI Stock Movement Today</h2>



Today&rsquo;s settlement news brings with it heavy trading of BFI shares. That has more than 14 million shares changing hands as of this writing. This is well above its daily average trading volume of about 564,000 shares.



BFI stock is up 71.4% as of Friday morning.



There are plenty more stock market stories worth reading about below!



We have all of the hottest stock market news available on Friday! Among that is what has shares of Windtree Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock up, the biggest pre-market stock movers and more. All of this news is ready at the links below!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-windtree-therapeutics-wint-stock-up-116-today/">Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Friday</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-zai-lab-zlab-stock-is-a-possible-hidden-gem/">Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-burgerfi-international-bfi-stock-up-71-today/">Why Is BurgerFi International (BFI) Stock Up 71% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is BurgerFi International (BFI) Stock Up 71% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
DexCom&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) stock is falling on Friday after the company released its earnings report for Q2 2024.



DexCom starts its earnings report with <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">adjusted earnings per share of 43 cents</a>. That&rsquo;s better than Wall Street&rsquo;s estimate of 39 cents per share. It&rsquo;s also an improvement over its adjusted EPS of 34 cents in the same period of the year prior.



However, the company&rsquo;s revenue of $1 billion failed to impress. It doesn&rsquo;t stack up to analysts&rsquo; estimate of $1.04 billion. Even if its a 15% increase year-over-year from $871.3 million.



Dexcom chairman, president and CEO Kevin Sayer said the following about the earnings report.




&ldquo;While Dexcom advanced several key strategic initiatives in the second quarter, our execution did not meet our high standards. We have a unique opportunity to serve millions of more customers around the world with our differentiated product portfolio and we are taking action to improve our execution and best position ourselves for continued long-term growth.&rdquo;




<h2>Guidance Cut Hits DXCM Stock Today</h2>



DXCM also updated its guidance in its latest earnings report. This has it expecting Q3 2024 revenue to range from $975 million to $1 billion. That would miss Wall Street&rsquo;s estimate of $1.15 billion in revenue.



For the full year of 2024, DexCom&nbsp;is predicting revenue of $4 to $4.05 billion. At the midpoint that would miss analysts&rsquo; estimate of $4.33 billion for the year.



DXCM stock is down 38.1% as of Friday morning with some 1.3 million shares traded. Its daily average trading volume is still above that at about 2.7 million shares.



We have more of the most recent stock market stories traders need to know about on Friday!



That includes all of the hottest market news news available today! A few examples include what&rsquo;s happening with shares of BurgerFi International&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>), Zai Lab&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/zlab-stock-quote/">ZLAB</a>) and Windtree Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock&nbsp;this morning. You can catch up on this news at the links below!



<h2>More Friday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-burgerfi-international-bfi-stock-up-71-today/">Why Is BurgerFi International (BFI) Stock Up 71% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-zai-lab-zlab-stock-is-a-possible-hidden-gem/">Trade of the Day: Zai Lab (ZLAB) Stock Is a Possible Hidden Gem</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-windtree-therapeutics-wint-stock-up-116-today/">Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/why-is-dexcom-dxcm-stock-down-38-today/">Why Is DexCom (DXCM) Stock Down 38% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is DexCom (DXCM) Stock Down 38% Today?

Windtree Therapeutics (WINT) has provided an announcement. Windtree Therapeutics, Inc. has experienced a shift in its Board of Directors, with Dani...

Windtree Therapeutics Board Reshuffles, Appoints New Directors

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) just reported results for the first quarter of 2024.<ul><li>Windtree Therapeutics reported earnings per share of -$20.91.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/wint-stock-earnings-windtree-therapeutics-for-q1-of-2024/">WINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

WINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024

Windtree Therapeutics GAAP EPS of -$20.91 misses by $18.64

Windtree Therapeutics files to sell 27.67M shares of common stock for holders

An announcement from Windtree Therapeutics ( ($WINT) ) is now available. The Company has been actively engaging in financial maneuvers, including e...

Windtree Therapeutics Expands Stock and Restructures Finances

AVGR

BLMZ

CREV

DXCM

EVRI

NMHI

OPTT

PAPL

SLNA

XCUR

ZLAB

ZPTA

ZYXI

Press Releases

Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research

Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

Earnings

Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

Windtree Therapeutics Announces Reverse Stock Split

Windtree Therapeutics Regains Compliance with Nasdaq

Financing

Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

Management

Windtree Announces New Additions and Changes to Its Board of Directors

Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates

Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Windtree Therapeutics

Windtree Therapeutics (WINT) Forecast

Windtree Therapeutics (NASDAQ:WINT) Stock, Quote.Headers.trade-ideas